Market Tracker

02/22 3:07am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.99
Delayed Data
As of Feb 21
 -0.07 / -1.38%
Today’s Change
3.17
Today|||52-Week Range
7.80
-14.85%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close5.06
Today’s open5.10
Day’s range4.93 - 5.13
Volume1,101,969
Average volume (3 months)1,507,276
Market cap$536.2M
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)-23.75%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book6.12

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.80+6.78%
RETAReata Pharmaceutical...-0.11-0.47%
ENTAEnanta Pharmaceutica...-0.63-2.16%
INOInovio Pharmaceutica...-0.16-2.30%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts